Santhera Pharmaceuticals Holding AG
General ticker "SPHDF" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $162.5M (TTM average)
Santhera Pharmaceuticals Holding AG does not follow the US Stock Market performance with the rate: -5.1%.
Estimated limits based on current volatility of 0.0%: low 13.35$, high 13.35$
Factors to consider:
- Earnings for 18 months up through Q2 (+1 year) are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [1.97$, 11.27$]
- 2024-12-30 to 2025-12-30 estimated range: [3.15$, 14.99$]
Short-term SPHDF quotes
Long-term SPHDF plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | CHF7.47MM | CHF103.41MM | CHF39.12MM |
| Operating Expenses | CHF59.45MM | CHF34.57MM | CHF72.50MM |
| Operating Income | CHF-51.98MM | CHF68.84MM | CHF-33.38MM |
| Non-Operating Income | CHF-18.64MM | CHF-14.02MM | CHF-8.28MM |
| Interest Expense | CHF20.19MM | CHF21.31MM | CHF20.17MM |
| R&D Expense | CHF30.54MM | CHF18.67MM | CHF26.47MM |
| Income(Loss) | CHF-70.62MM | CHF54.82MM | CHF-41.66MM |
| Taxes | CHF0.00MM | CHF0.04MM | CHF0.31MM |
| Profit(Loss)* | CHF-71.08MM | CHF54.78MM | CHF-41.97MM |
| Stockholders Equity | CHF-43.69MM | CHF59.94MM | CHF27.70MM |
| Inventory | CHF0.11MM | CHF1.81MM | CHF17.53MM |
| Assets | CHF63.73MM | CHF109.63MM | CHF152.49MM |
| Operating Cash Flow | CHF-29.84MM | CHF47.27MM | CHF-35.53MM |
| Capital expenditure | CHF3.96MM | CHF23.74MM | CHF0.15MM |
| Investing Cash Flow | CHF-3.93MM | CHF-18.04MM | CHF-0.06MM |
| Financing Cash Flow | CHF13.99MM | CHF-0.17MM | CHF46.08MM |
| Earnings Per Share** | CHF-11.67 | CHF5.18 | CHF-3.69 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.